Safety and Immunogenicity of NVX-CoV2705

Clinical trial NCT07079670 · COMPLETED

Trial details

NCT number: NCT07079670
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection

Start date: 2025-10-09
Primary completion: 2026-01-12
Enrollment: 676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.